BE827572A - Vaccin a base de cytomegalovirus fortement attenues et sa production - Google Patents

Vaccin a base de cytomegalovirus fortement attenues et sa production

Info

Publication number
BE827572A
BE827572A BE155098A BE155098A BE827572A BE 827572 A BE827572 A BE 827572A BE 155098 A BE155098 A BE 155098A BE 155098 A BE155098 A BE 155098A BE 827572 A BE827572 A BE 827572A
Authority
BE
Belgium
Prior art keywords
production
highly expected
cytomegalovirus vaccine
cytomegalovirus
vaccine
Prior art date
Application number
BE155098A
Other languages
English (en)
French (fr)
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed filed Critical
Publication of BE827572A publication Critical patent/BE827572A/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/12—Viral antigens
    • A61K39/245—Herpetoviridae, e.g. herpes simplex virus
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/12—Viral antigens
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
    • A61K2039/525—Virus
    • A61K2039/5254—Virus avirulent or attenuated
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2710/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsDNA viruses
    • C12N2710/00011—Details
    • C12N2710/16011—Herpesviridae
    • C12N2710/16111—Cytomegalovirus, e.g. human herpesvirus 5
    • C12N2710/16134—Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Virology (AREA)
  • Chemical & Material Sciences (AREA)
  • Immunology (AREA)
  • Medicinal Chemistry (AREA)
  • Microbiology (AREA)
  • Mycology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
BE155098A 1974-04-15 1975-04-04 Vaccin a base de cytomegalovirus fortement attenues et sa production BE827572A (fr)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US05/460,951 US3959466A (en) 1974-04-15 1974-04-15 Highly attenuated cytomegalovirus vaccine and production thereof

Publications (1)

Publication Number Publication Date
BE827572A true BE827572A (fr) 1975-10-06

Family

ID=23830680

Family Applications (1)

Application Number Title Priority Date Filing Date
BE155098A BE827572A (fr) 1974-04-15 1975-04-04 Vaccin a base de cytomegalovirus fortement attenues et sa production

Country Status (11)

Country Link
US (1) US3959466A (xx)
JP (1) JPS58406B2 (xx)
BE (1) BE827572A (xx)
CA (1) CA1045546A (xx)
CH (1) CH617588A5 (xx)
DE (1) DE2516274C2 (xx)
FR (1) FR2267117B1 (xx)
GB (1) GB1501724A (xx)
NL (1) NL7504480A (xx)
SE (1) SE7504221L (xx)
ZA (1) ZA751949B (xx)

Families Citing this family (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4058598A (en) * 1974-10-18 1977-11-15 Harold Stern Cytomegalovirus attenuation method and vaccine
AU532186B2 (en) * 1978-07-21 1983-09-22 Merck & Co., Inc. Herpes virus vaccine
US6133433A (en) * 1984-07-27 2000-10-17 City Of Hope Method for detection and prevention of human cytomegalovirus infection
US6242567B1 (en) 1984-07-27 2001-06-05 City Of Hope Method for detection and prevention of human cytomegalovirus infection
US5194256A (en) * 1984-08-21 1993-03-16 The Board Of Trustees Of The Leland Sanford Junior University Purified human cytomegalovirus protein
US4689225A (en) * 1984-11-02 1987-08-25 Institut Merieux Vaccine for cytomegalovirus
US5126130A (en) * 1986-11-24 1992-06-30 The Childrens Hospital Incorporated Monoclonal antibodies reactive with specific antigenic sites on human cytomegalovirus glycoprotein a
US5248768A (en) * 1986-11-24 1993-09-28 The Children's Hospital, Incorporated Immunogenic glycoproteins of human cytomegalovirus
US5153311A (en) * 1986-11-24 1992-10-06 The Children's Hospital, Incorporated Immunogenic glycoproteins of human cytomegalovirus gCII
EP0277773A1 (en) * 1987-01-30 1988-08-10 The Board Of Trustees Of The Leland Stanford Junior University Hybrid cytomegalovirus (CMV) and vaccine
US5591439A (en) * 1989-03-24 1997-01-07 The Wistar Institute Of Anatomy And Biology Recombinant cytomegalovirus vaccine
US5552143A (en) * 1989-03-24 1996-09-03 The Wistar Institute Of Anatomy & Biology Recombinant cytomegalovirus vaccine
US5180813A (en) * 1989-03-24 1993-01-19 University Of Iowa Research Foundation Early envelope glycoprotein of human cytomegalovirus (hmcv) and monoclonal antibodies to the glycoproteins
US6448389B1 (en) 1996-04-23 2002-09-10 The Wistar Institute Of Anatomy And Biology Human cytomegalovirus DNA constructs and uses therefor
US6835383B2 (en) * 2000-03-23 2004-12-28 City Of Hope Protein kinase deficient, immunologically active CMVpp65 mutants
EP1178111A1 (en) * 2000-08-03 2002-02-06 Lohmann Animal Health GmbH & Co. KG Vaccination against host cell-associated herpesviruses
US6692954B1 (en) 2000-11-03 2004-02-17 The Scripps Research Institute Generation of human cytomegalovirus yeast artificial chromosome recombinants
US9439960B2 (en) 2007-10-10 2016-09-13 The Trustees Of Princeton University Cytomegalovirus vaccines and methods of production
WO2021014398A1 (en) 2019-07-23 2021-01-28 University Of Rijeka Faculty Of Medicine Integrated human cytomegalovirus / glioblastoma vaccine

Also Published As

Publication number Publication date
FR2267117A1 (xx) 1975-11-07
SE7504221L (sv) 1975-12-22
JPS58406B2 (ja) 1983-01-06
US3959466A (en) 1976-05-25
CH617588A5 (xx) 1980-06-13
AU8002475A (en) 1976-10-14
DE2516274C2 (de) 1986-10-30
NL7504480A (nl) 1975-10-17
DE2516274A1 (de) 1975-10-23
CA1045546A (en) 1979-01-02
FR2267117B1 (xx) 1978-11-24
ZA751949B (en) 1976-02-25
GB1501724A (en) 1978-02-22
JPS5115612A (xx) 1976-02-07

Similar Documents

Publication Publication Date Title
BE827572A (fr) Vaccin a base de cytomegalovirus fortement attenues et sa production
DK143386C (da) Cyclonseparator
SE7512044L (sv) Cyklonanordning
SE7604818L (sv) Vaccin
IT1028274B (it) Apparecchio di scintigrafia ibri da a scansione
BR7503929A (pt) Comprimido efervescente hidrossoluvel
DK549275A (da) Kapsel
BE825577A (fr) Appareil a toupiller
IT1031760B (it) Termistri a base di pirocloro
PL96711B1 (pl) Srodek chwastobojczy
IL46426A (en) Influenza vaccines and their production
FR2294925A1 (fr) Cagette a claires-voies
SE393686B (sv) Seismograf
BE827157A (fr) Vaccin contre la rhinotracheite feline et sa production
AT341775B (de) Thermoplastische massen
DK418075A (da) Anti-arrhytmiske midler
BR7501008A (pt) Queimador a oxi-oleo
BE827145A (fr) Vaccin
JPS5126660A (ja) Kahenparusuaakuyosetsuho
AT332591B (de) Mobelsockel
JPS5165220A (ja) Jetsutoenjin
JPS5154539A (ja) Tetoraburomuubisufuenooru a no seiseihoho
IT1042960B (it) Dispositivo a bacla
FR2291196A1 (fr) Le perchloro-diaza-fulvene et sa preparation
IT1052335B (it) Complesso a faro

Legal Events

Date Code Title Description
RE Patent lapsed

Owner name: THE WISTAR INSTITUTE OF ATOMY AND BIOLOGY

Effective date: 19900430